It is traditionally believed that men and women experience angina—the pain associated with coronary artery disease—in different ways, with men feeling it in their chest and women feeling it in their arms and back.

PathAI, a Boston-based healthcare technology company, has found that AI can help specialists quantify PD-L1 expression on both tumor cells and immune cells.

Cancer Research UK, one of the world’s largest charities focused on improving cancer treatments, has launched a new research network focused on advanced radiotherapy techniques, immunotherapies and AI.

Researchers from the University at Buffalo in New York are working to turn a $200,000 grant into groundbreaking diabetes research.

Numerous healthcare providers and technology companies are working together on a new research project focused on using AI to improve care for patients with subarachnoid hemorrhages and diabetes.

CMS announced Thursday, Oct. 31, that 25 participants have advanced in the agency’s Artificial Intelligence Health Outcomes Challenge, putting them one step closer to earning $1 million in prize money.

Deep learning can provide accurate measurements of a patient’s musculoskeletal (MSK) system by evaluating CT scans, according to findings published in IEEE Transactions on Medical Imaging.

Facebook and the NYU School of Medicine made headlines back in August 2018 when they announced their plan to improve MRI times using AI.

Researchers have uncovered a new way to determine when ductal carcinoma in situ (DCIS) is most likely to progress to a more invasive cancer, according to new findings published in Breast Cancer Research.

People often stare at their phones while using the restroom, scrolling through emails and social media posts to help pass the time. Now, however, two companies are asking phone-toting individuals to do something else before they flush: snap a quick photo of their poop.

AI algorithms can identify melanomas in dermoscopic images with an accuracy comparable to human specialists, according to research published in JAMA.

Regina Barzilay, PhD, a professor at the Massachusetts Institute of Technology, has been working closely with AI technologies to improve breast cancer care ever since she was diagnosed with the disease in 2014.